Phenotypic and molecular spectrum of Korean patients with Lesch-Nyhan syndrome and attenuated clinical variants.
HPRT1
Hyperuricemia
Hypoxanthine guanine phosphoribosyltransferase
Lesch-Nyhan syndrome
Journal
Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
19
02
2019
accepted:
20
05
2019
pubmed:
28
5
2019
medline:
1
5
2020
entrez:
27
5
2019
Statut:
ppublish
Résumé
Lesch-Nyhan syndrome (LNS) is an X-linked recessive disorder caused by mutations in the HPRT1 gene. The clinical features and mutation spectrum of 26 Korean LNS patients from 23 unrelated families were retrospectively reviewed. The HPRT1 gene was analyzed by direct sequencing of genomic DNA. The median age at diagnosis was 2.3 years (range, 4 months-22.6 years) and the initial presenting features included developmental delay, orange colored urine, and self-injurious behaviors. Most patients were wheelchair-bound and suffered from urinary complications and neurologic problems such as self-mutilation and developmental delay. Twenty different mutations in HPRT1 were identified among 23 independent pedigrees, including six novel mutations. The most common mutation type was truncating mutations including nonsense and frameshift mutations (45%). Large deletions in the HPRT1 gene were identified in exon 1, exons 5-6, exons 1-9, and at chr X:134,459,540-134,467,241 (7702 bp) including the 5'-untranslated region, exon 1, and a portion of intron 1. In conclusion, this study describes the phenotypic spectrum of LNS and has identified 20 mutations from 23 Korean families, including six novel mutations in Korean patients with LNS.
Identifiants
pubmed: 31129767
doi: 10.1007/s11011-019-00441-0
pii: 10.1007/s11011-019-00441-0
doi:
Substances chimiques
Hypoxanthine Phosphoribosyltransferase
EC 2.4.2.8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1335-1340Références
Proc Natl Acad Sci U S A. 1967 Jun;57(6):1735-9
pubmed: 4291947
Dev Med Child Neurol. 2006 Nov;48(11):923-6
pubmed: 17044962
Mol Genet Metab. 2015 Jan;114(1):55-61
pubmed: 25481104
Adv Exp Med Biol. 1994;370:679-82
pubmed: 7660995
Mutat Res. 2010 Oct 13;692(1-2):1-5
pubmed: 20638392
Mutat Res. 1998 Nov;411(3):179-214
pubmed: 9804951
Orphanet J Rare Dis. 2007 Dec 08;2:48
pubmed: 18067674
Brain. 2010 Mar;133(Pt 3):671-89
pubmed: 20176575
Brain. 2014 May;137(Pt 5):1282-303
pubmed: 23975452
Mol Genet Metab. 2013 Nov;110(3):268-74
pubmed: 24075303
Mol Genet Metab. 2012 Aug;106(4):498-501
pubmed: 22766437
J Autism Dev Disord. 2001 Dec;31(6):577-88
pubmed: 11814269
J Korean Med Sci. 1997 Aug;12(4):332-9
pubmed: 9288634
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S447-51
pubmed: 19016344
Brain Dev. 2014 Nov;36(10):921-3
pubmed: 24503445
Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1153-60
pubmed: 15571220
Arch Neurol. 2008 Sep;65(9):1240-3
pubmed: 18779430
Mol Cell Biol. 1986 Feb;6(2):393-403
pubmed: 3023844
J Inherit Metab Dis. 1990;13(2):178-83
pubmed: 2116548
Mol Genet Metab. 2014 Aug;112(4):280-5
pubmed: 24930028
Am J Med. 1964 Apr;36:561-70
pubmed: 14142409
PLoS One. 2017 Mar 10;12(3):e0173512
pubmed: 28282408
Mutat Res. 2000 Oct;463(3):309-26
pubmed: 11018746
Urol Res. 2011 Oct;39(5):417-9
pubmed: 21331772
Pediatr Res. 1972 May;6(5):504-13
pubmed: 4558815